Buys
Open market- Shares
- Avg price
- Total value
Louis G. Lange - Director at NewAmsterdam Pharma Co N.V.
Issuer-level insider activity
- Role
- Director
- Issuer ticker
- NAMS, NAMSW on Nasdaq
- Entity type
- Individual
- Source filing history
- Open source filing history
Identity
Names, identifiers, and filing context for this profile.
1 identity field
Source evidence
Original filing metadata and source links for verification.
1 source field
Past-year transaction volume for Louis G. Lange in NewAmsterdam Pharma Co N.V.
Sells
Open market- Shares
- -72,805
- Avg price
- $30.03
- Total value
- -$2,186,180
Net
Past year- Shares
- -72,805
- Share %
- -100%
- Total value
- -$2,186,180
Reported holdings for Louis G. Lange in NewAmsterdam Pharma Co N.V.
Form 4 holding
Director
NewAmsterdam Pharma Co N.V.
- Security class
- Ordinary Shares
- Shares / value
- 10,360
- Estimated value
- $323,542
- Report date
- 11 Mar 2026
- Price
- $31.23
- Ownership
- Direct
Form 4 holding
Director
NewAmsterdam Pharma Co N.V.
- Security class
- Option (right to buy)
- Shares / value
- 15,300
- Estimated value
- Report date
- 07 Jan 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Director
NewAmsterdam Pharma Co N.V.
- Security class
- Restricted Stock Unit
- Shares / value
- 0
- Estimated value
- Report date
- 01 Jun 2025
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Form 4 holding
Director
NewAmsterdam Pharma Co N.V.
- Security class
- Warrant (right to buy)
- Shares / value
- 0
- Estimated value
- Report date
- 09 Mar 2026
- Price
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
Transaction history for Louis G. Lange in NewAmsterdam Pharma Co N.V.
| Sym | Class | Transaction | % | SEC-reported value | SEC-reported price | Shares | Shares after | Date | Ownership |
|---|
* marks a reported price that did not pass the local price check.